CLINICAL_TRIALS
trial_result
· 2020-08-12
Clinical Trial Update: Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors [Phase 2]
Summary
A Phase II pediatric trial of pazopanib sponsored by Novartis under the Children's Oncology Group has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Solid Tumours | Phase 2 | Status: COMPLETED | Results posted: 2020-08-12